KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amgen (AMGN) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to $2.1 billion.

  • Amgen's Non Operating Income rose 1366.12% to $2.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 billion, marking a year-over-year increase of 4331.36%. This contributed to the annual value of $506.0 million for FY2024, which is 8213.91% down from last year.
  • Per Amgen's latest filing, its Non Operating Income stood at $2.1 billion for Q3 2025, which was up 1366.12% from -$394.0 million recorded in Q2 2025.
  • In the past 5 years, Amgen's Non Operating Income ranged from a high of $2.1 billion in Q3 2025 and a low of -$782.0 million during Q4 2024
  • For the 5-year period, Amgen's Non Operating Income averaged around $315.2 million, with its median value being $13.0 million (2021).
  • As far as peak fluctuations go, Amgen's Non Operating Income crashed by 417692.31% in 2022, and later soared by 74595.74% in 2025.
  • Over the past 5 years, Amgen's Non Operating Income (Quarter) stood at $162.0 million in 2021, then crashed by 141.36% to -$67.0 million in 2022, then skyrocketed by 700.0% to $402.0 million in 2023, then tumbled by 294.53% to -$782.0 million in 2024, then surged by 365.98% to $2.1 billion in 2025.
  • Its last three reported values are $2.1 billion in Q3 2025, -$394.0 million for Q2 2025, and $1.5 billion during Q1 2025.